Australia Clears Novartis' Alcon Buy With Conditions
Australia's competition regulator said Thursday that it would not oppose Novartis AG's acquisition of a majority stake in Alcon Laboratories Inc., after Novartis agreed to sell off some of Alcon's eye...To view the full article, register now.
Already a subscriber? Click here to view full article